Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,834Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Allelock

02 7Patanol

03 1Topical Olopatadine Group

04 2Topical Olopatadine Group

PharmaCompass

01

Brand Name : Patanol

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Patanol

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 101

2019 Revenue in Millions : 129

Growth (%) : -22

blank

02

Brand Name : Allelock

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Allelock

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 82

2019 Revenue in Millions : 102

Growth (%) : -20

blank

03

Brand Name : Patanol

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Patanol

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 90

2020 Revenue in Millions : 101

Growth (%) : 1

blank

04

Brand Name : Allelock

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Allelock

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 68

2020 Revenue in Millions : 82

Growth (%) : -7

blank

05

Brand Name : Allelock

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Allelock

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 45

2021 Revenue in Millions : 68

Growth (%) : -33

blank

06

Brand Name : Patanol

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Patanol

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 21

2021 Revenue in Millions : 90

Growth (%) : -77

blank

07

Brand Name : Allelock

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Allelock

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 37

2022 Revenue in Millions : 45

Growth (%) : -8

blank

08

Brand Name : Patanol

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Patanol

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 13

2022 Revenue in Millions : 21

Growth (%) : -29

blank

09

Brand Name : Allelock

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Allelock

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Anti-allergic

Currency : USD

2017 Revenue in Millions : 153

2016 Revenue in Millions : 175

Growth (%) : -13

blank

10

Brand Name : Patanol

Olopatadine Hydrochloride

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Patanol

arrow
2024 ACI Convention
Not Confirmed

Olopatadine Hydrochloride

Main Therapeutic Indication : Anti-allergic

Currency : USD

2017 Revenue in Millions : 123

2016 Revenue in Millions : 125

Growth (%) : -2

blank